Predictors and long-term patterns of medication adherence to glaucoma treatment in Denmark-an observational registry study of 30 100 Danish patients with glaucoma

被引:1
作者
Kolko, Miriam [1 ,2 ]
Hansen, Rikke Faergemann [3 ]
Dal, Louise G. [4 ]
Sabelstrom, Emma [4 ]
Brandel, Magnus [4 ]
Bentsen, Andreas Hoiberg [3 ]
Falch-Joergensen, Anne Cathrine [3 ]
机构
[1] Univ Copenhagen, Fac Hlth Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark
[2] Rigshosp Glostrup, Rigshospitalet Glostrup, Glostrup, Denmark
[3] Real World Evidence, Signum Life Sci, Copenhagen, Denmark
[4] AbbVie A S, Copenhagen, Denmark
关键词
Glaucoma; Epidemiology; Public health; Treatment Medical; VISUAL-FIELD PROGRESSION; OCULAR HYPERTENSION; INTRAOCULAR-PRESSURE; INTERVENTION; AGIS; BARRIERS; DISEASE; QUALITY; SYSTEM; COSTS;
D O I
10.1136/bmjophth-2023-001607
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background Self-treatment with glaucoma medication (eye drops) has been associated with adherence challenges. Poor adherence results in worse outcomes in terms of visual field loss.Objective To investigate patterns in medication adherence among Danish patients with glaucoma in relation to selected predictors of adherence, long-term adherence patterns, and long-term societal economic consequences of poor adherence.Methods and analysis This register-based study included 30 100 glaucoma patients followed for 10 years between 2000 and 2018. Glaucoma was identified from the Danish national registers by diagnosis of Open Angle Glaucoma and/or by redeemed prescriptions of glaucoma medication. Logistic regression models were applied to estimate patient characteristics related to medical adherence. Diagnosis-related group fees were applied to estimate healthcare costs.Results High adherence in the first year(s) of treatment was less likely among men (ORfirst year: 0.78, 95% CI: 0.75 to 0.82), younger individuals and among those with a positive Charlson Comorbidity Index (CCI) score (ORfirst year/CCI >= 3: 0.71, 95% CI: 0.63 to 0.80). Adherence in the first year and in the first two years was associated with adherence in the fifth (ORfirst year: 4.55, 95% CI: 4.30 to 4.82/ORfirst two years: 6.47, 95% CI: 6.10 to 6.86) as with adherence in the 10th year with slightly lower estimates. Being medical adherent was related to higher costs related to glaucoma medication after 5 and 10 years comparing with poor adherence, whereas poor adherence was associated with a marked increase in long-term costs for hospital contacts.Conclusion Increasing age, female sex and low comorbidity score are correlated with better adherence to glaucoma treatment. Adherence in the first years of treatment may be a good predictor for future adherence. In the long term, patients with poor adherence are overall more expensive to society in terms of hospital contacts.
引用
收藏
页数:9
相关论文
共 48 条
[1]   Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future [J].
Allison, Karen ;
Patel, Deepkumar ;
Alabi, Omobolanle .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (11)
[2]   Impact of Comorbidities on Tumor Necrosis Factor Inhibitor Therapy in Psoriatic Arthritis: A Population-Based Cohort Study [J].
Ballegaard, Christine ;
Hojgaard, Pil ;
Dreyer, Lene ;
Cordtz, Rene ;
Jorgensen, Tanja Schjodt ;
Skougaard, Marie ;
Tarp, Simon ;
Kristensen, Lars Erik .
ARTHRITIS CARE & RESEARCH, 2018, 70 (04) :592-599
[3]   Improving adherence to glaucoma medication: a randomised controlled trial of a patient-centred intervention (The Norwich Adherence Glaucoma Study) [J].
Cate, Heidi ;
Bhattacharya, Debi ;
Clark, Allan ;
Fordham, Richard ;
Holland, Richard ;
Broadway, David C. .
BMC OPHTHALMOLOGY, 2014, 14
[4]   Economic impact of medication non-adherence by disease groups: a systematic review [J].
Cutler, Rachelle Louise ;
Fernandez-Llimos, Fernando ;
Frommer, Michael ;
Benrimoj, Charlie ;
Garcia-Cardenas, Victoria .
BMJ OPEN, 2018, 8 (01)
[5]   Current Medical Therapy and Future Trends in the Management of Glaucoma Treatment [J].
Cvenkel, Barbara ;
Kolko, Miriam .
JOURNAL OF OPHTHALMOLOGY, 2020, 2020
[6]   The Medical and Surgical Treatment of Glaucoma [J].
Dietlein, Thomas S. ;
Hermann, Manuel M. ;
Jordan, Jens F. .
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2009, 106 (37) :597-BR1
[7]  
eSundhed, 2017, Documentation of registers
[8]  
DRG grouped National Patient Regsiter Data
[9]   Adherence to Glaucoma Medications Over 12 Months in Two US Community Pharmacy Chains [J].
Feehan, Michael ;
Munger, Mark A. ;
Cooper, Daniel K. ;
Hess, Kyle T. ;
Durante, Richard ;
Jones, Gregory J. ;
Montuoro, Jaime ;
Morrison, Margaux A. ;
Clegg, Daniel ;
Crandall, Alan S. ;
DeAngelis, Margaret M. .
JOURNAL OF CLINICAL MEDICINE, 2016, 5 (09)
[10]   Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis [J].
Flaxman, Seth R. ;
Bourne, Rupert R. A. ;
Resnikoff, Serge ;
Ackland, Peter ;
Braithwaite, Tasanee ;
Cicinelli, Maria V. ;
Das, Aditi ;
Jonas, Jost B. ;
Keeffe, Jill ;
Kempen, John H. ;
Leasher, Janet ;
Limburg, Hans ;
Naidoo, Kovin ;
Pesudovs, Konrad ;
Silvester, Alex ;
Stevens, Gretchen A. ;
Tahhan, Nina ;
Wong, Tien Y. ;
Taylor, Hugh R. .
LANCET GLOBAL HEALTH, 2017, 5 (12) :E1221-E1234